SCHEMBL6603263

SCHEMBL6603263

CC(C)(C)c1ccc(C2CC(O)=CC(=O)O2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 1/20 0.39
SLC6A3 Q01959 1/20 0.39
ESR2 Q92731 4/20 0.36
ESR1 P03372 3/20 0.36
LMNA P02545 1/20 0.36
TYR P14679 1/20 0.36
CYP19A1 P11511 4/20 0.35
CYP3A4 P08684 3/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
ADORA3 P0DMS8 2/20 0.35
MAPT P10636 2/20 0.35
TUBB4A P04350 1/20 0.35
TUBB P07437 1/20 0.35
YES1 P07947 1/20 0.35
TUBA3C P0DPH7 1/20 0.35
TUBA1B P68363 1/20 0.35
TUBA4A P68366 1/20 0.35
TUBB4B P68371 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6603604 0.85 CYP19A1 (0.35) ESR2ESR1CYP19A1CYP3A4NPC1
SCHEMBL6607888 0.83 MAOB (0.48) ESR2ESR1LMNAMEN1KMT2A
SCHEMBL31607964 0.82 CYP19A1 (0.50) ESR2ESR1CYP19A1CYP3A4NPC1
SCHEMBL6602817 0.80 ALOX12 (0.53) ESR2ESR1CYP19A1CYP3A4NPC1
SCHEMBL6605596 0.79 CYP19A1 (0.35) ESR2ESR1CYP19A1CYP3A4NPC1
SCHEMBL6602578 0.79 CYP1A1 (0.52) CYP19A1CYP3A4NPC1RAB9AADORA3
SCHEMBL6609372 0.77 ADORA3 (0.42) LMNACYP19A1CYP3A4NPC1RAB9A
SCHEMBL9050290 0.75 ESR2 (0.35) SLC6A2SLC6A4SLC6A3ESR2ESR1
SCHEMBL30528494 0.75 TNKS2 (0.41) SLC6A2SLC6A4SLC6A3CYP19A1CYP3A4
SCHEMBL12673928 0.75 KDM4E (0.55) ESR2ESR1CYP19A1CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1142887-B1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents PARKE DAVIS & CO (US) 2004-04-07 EP disclosed
EP-0729463-B1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2002-05-22 EP disclosed
EP-1142887-A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents PARKE, DAVIS & COMPANY (US) 2001-10-10 EP disclosed
US-5936128-A BENZENETHIOL COMPOUNDS AS INTERMEDIATES; BACTERICIDES, VIRICIDES; HIV WARNER-LAMBERT COMPANY (US) 1999-08-10 US disclosed
US-5840751-A ADMINISTERING IN THE TREATMENT OF INFECTION OR DISEASE CAUSED BY A RETROVIRUS WARNER-LAMBERT COMPANY (US) 1998-11-24 US disclosed
US-5789440-A 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents WARNER-LAMBERT COMPANY (US) 1998-08-04 US disclosed
EP-0729463-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729464-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014012-A1 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014011-A2 5,6-DIHYDROPYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed